Abstract
Although a large body of structural data exists for bronchial mucins from cystic fibrosis (CF) and chronic bronchitis (CB) patients, little is known about terminal structures carried on poly-N-acetyllactosamine antennae. Such structures are of interest because they are potential ligands for bacterial adhesins and other lectins. In this study, we have used fast atom bombardment mass spectrometry (FAB-MS) to examine terminal sequences released by endo-β-galactosidase from O-glycans obtained by reductive elimination of bronchial mucins purified from the sputum of 8 CF and 8 CB patients. Our data show that, although the polylactosamine antennae of CF and CB mucins have several terminal sequences in common, they differ significantly in their sialyl Lewisx (NeuAcα2-3Galβ1-4[Fucα1-3]GlcNAcβ1-) content. Thus all examined mucins from CF patients carry sialyl Lewisx on their polylactosamine antennae, whereas this type of epitope is present on only three out of the eight CB mucins examined, notably in the airways of one CB patient which were heavily infected by Pseudomonas aeruginosa as are the airways of all the CF patients. This suggests that, in airway mucins, the expression of sialyl Lewisx on polylactosamine antennae is probably more related to inflammation and infection than to a direct effect of the CF defect.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Lamblin G, Degroote S, Perini JM, Delmotte P, Scharfman A, Davril M, Lo-Guidice JM, Houdret N, Dumur V, Klein A, Roussel P, Human airway mucin glycosylation:Acombinatory of carbohydrate determinants which vary in Cystic Fibrosis,Glycoconjugate J 18,661–84 (2001).
Zielenski J, Tsui LC, Cystic fibrosis: Genotypic and Phenotypic Variations,Annu Rev Genet 29,777–807 (1995).
Devidas S, Guggino WB, CFTR: Domains, structure, and function, Bioenerg Biomembr 29, 443–51 (1997).
Schwiebert EM, Benos DJ, Egan ME, Stutts MJ, Guggino WB, CFTR is a conductance regulator as well as a chloride channel, Physiol Rev 79, S145–66 (1999).
Carnoy C, Ramphal R, Scharfman A, Lo-Guidice JM, Houdret N, Klein A, Galabert C, Lamblin G, Roussel P, Altered carbohydrate composition of salivary mucins from patients with cystic fibrosis and the adhesion of Pseudomonas aeruginosa, Am J Respir Cell Mol Biol 9, 323–34 (1993).
Devaraj N, Sheykhnazari M, Warren WS, Bhavanandan VP, Differential binding of Pseudomonas aeruginosa to normal and cystic fibrosis tracheobronchial mucins, Glycobiology 4, 307–16 (1994).
Birrer P, McElvaney NG, Rudeberg A, Sommer CW, Liechti-Gallati S, Kraemer R, Hubbard R, Crystal RG, Proteaseantiprotease imbalance in the lungs of children with cystic fibrosis, Am J Respir Crit Care Med 150, 207–13 (1994).
Konstan_MW, Hilliard KA, Norvell TM, Berger M, Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung diseases suggest ongoing infection and inflammation, Am J Respir Crit Care Med 150, 448–54 (1994).
Bonfield TL, Panuska JR, Konstan MW, Hilliard KA, Hilliard JB, Ghnaim H, Berger M, Inflammatory cytokines in cystic fibrosis lungs, Am J Respir Crit Care Med 152, 2111–8 (1995).
Bonfield TL, Konstan MW, Burfeind P, Panuska JR, Hilliard JB, Berger M, Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis, Am J Respir Cell Mol Biol 13, 257–61 (1995).
Heeckeren A, Walenga R, Konstan MW, Bonfield T, Davis PB, Ferkol T, Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa, J Clin Invest 100, 2810–5 (1997).
Sajjan U, Thanassoulis G, Cherapanov V, Lu A, Sjolin C, Steer B, Wu YJ, Rotstein OD, Kent G, McKerlie C, Forstner J, Downey P, Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr ?/? mice, Infect Immun 69, 5138–50 (2001).
Davril M, Degroote S, Humbert P, Galabert C, Dumur V, Lafitte JJ, Lamblin, Roussel P, The sialylation of bronchial mucins secreted by patients suffering from cystic fibrosis or from chronic bronchitis is related to the severity of airway infection, Glycobiology 9, 311–21 (1999).
Lamblin G, Boersma A, Klein A, Roussel P, van Halbeek H, Vliegenthart JFG, Primary structure determination of five sialylated oligosaccharides derived from bronchial mucus glycoproteins of patients suffering from cystic fibrosis. The occurence of the NeuAc?(2,3)Gal?(1,4)[Fuc?(1,3)]GlcNAc?(1-) structural element revealed by 500-MHz 1H NMR spectroscopy, J Biol Chem 259, 9051–8 (1984).
Klein A, Carnoy C, Lamblin G, Roussel P, van Kuik JA, Vliegenthart JFG, Isolation and structural characterization of novel sialylated oligosaccharide-alditols from respiratory-mucus glycoproteins of a patient suffering from bronchiectasis, Eur J Biochem 211, 491–500 (1993).
Lo-Guidice JM, Wieruszeski JM, Lemoine J, Verbert A, Roussel P, Lamblin G, Sialylation and sulfation of the carbohydrate chains in respiratory mucins from a patient with cystic fibrosis, J Biol Chem 269, 18794–813 (1994).
Crottet P, Kim YJ, Varki A, Subsets of sialylated, sulfated mucins of diverse origins are recognized by L-selectin. Lack of evidence for unique oligosaccharide sequences mediating binding, Glycobiology 6, 191–208 (1996).
Engelhardt JF, Zepeda M, Cohn JA, Yankaskas JR, Wilson JM, Expression of the cystic fibrosis gene in adult human lung, J Clin Invest 93, 737–49 (1994).
Jacquot J, Puchelle E, Hinnrasky J, Fuchey C, Bettinger C, Spilmont C, Bonnet N, Dieterle A, Dreyer D, Pavirani A, et al. Localization of the cystic fibrosis transmembrane conductance regulator in airway secretory glands, Eur Respir J 6, 169–76 (1993).
Delmotte P, Degroote S, Lafitte JJ, Lamblin G, Perini JM, Roussel P, Tumor necrosis factor alpha increases the expression of glycosyltransferases and sulfotransferases responsible for the biosynthesis of sialylated and/or sulfated Lewis x epitopes in the human bronchial mucosa, J Biol Chem 277, 424–31 (2002).
Scharfman A, Arora SK, Delmotte P, Van Brussel E, Mazurier J, Ramphal R, Roussel P, Recognition of Lewis x derivatives present on mucins by flagellar components of Pseudomonas aeruginosa, Infect Immun 69, 5243–8 (2001).
Ramphal R, Arora SK, Recognition of specific mucin components by Pseudomonas aeruginosa, Glycoconjugate J 18, 709–13 (2001).
Dell A, Reason AJ, Khoo K-H, Panico M, McDowell RA, Morris HR, Mass spectrometry of carbohydrate containing biopolymers, Practical considerations, Methods Enzymol 230, 108–32 (1994).
Albersheim P, Nevins DJ, English PD, Karr A, A method for the analysis of sugars in plant cell wall polysaccharides by gas-liquid chromatography, Carbohydr Res 5, 340–5 (1967).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Morelle, W., Sutton-Smith, M., Morris, H.R. et al. FAB-MS characterization of sialyl Lewisx determinants on polylactosamine chains of human airway mucins secreted by patients suffering from cystic fibrosis or chronic bronchitis. Glycoconj J 18, 699–708 (2001). https://doi.org/10.1023/A:1020871322769
Issue Date:
DOI: https://doi.org/10.1023/A:1020871322769